UKIACR average (population) | UKIACR average (country) | England | Scotland | Wales | Northern Ireland | Republic of Ireland | |
---|---|---|---|---|---|---|---|
All invasive xnmsc | 76.8% | 69.4% | 80.4% | 60.8% | 65.1% | 82.4% | 58.1% |
Haematology | 57.1% | 27.5% | 68.6% | 0.0% | 0.0% | 68.9% | 0.0% |
Head and Neck | 77.5% | 65.8% | 87.7% | 0.0% | 84.1% | 96.1% | 60.9% |
Lower GI | 86.9% | 81.6% | 89.7% | 73.2% | 81.1% | 92.2% | 71.9% |
Upper GI | 78.2% | 69.6% | 82.1% | 62.6% | 78.3% | 70.8% | 54.2% |
HPB | 67.7% | 65.1% | 68.9% | 65.6% | 54.7% | 74.6% | 61.5% |
Trachea, Bronchus & Lung | 89.6% | 84.2% | 91.5% | 90.3% | 84.9% | 92.2% | 62.3% |
Melanoma | 88.4% | 79.5% | 93.7% | 40.9% | 78.1% | 97.8% | 86.8% |
Breast | 90.4% | 84.9% | 92.8% | 84.3% | 76.6% | 95.7% | 75.2% |
Cervix | 81.4% | 83.4% | 80.6% | 91.8% | 80.7% | 96.3% | 67.7% |
Other Female Genitals | 82.9% | 74.0% | 86.5% | 70.2% | 69.1% | 81.8% | 62.3% |
Prostate | 87.0% | 79.9% | 90.1% | 77.9% | 77.2% | 91.4% | 63.0% |
Bladder | 81.3% | 70.9% | 86.1% | 53.9% | 64.8% | 89.2% | 60.5% |
Kidney | 82.9% | 77.4% | 85.6% | 65.4% | 72.4% | 91.4% | 72.1% |
Thyroid and other endocrine glands | 65.6% | 64.8% | 69.6% | 0.0% | 86.2% | 98.8% | 69.6% |
Other invasive cancer | 56.4% | 46.6% | 61.3% | 19.0% | 35.3% | 70.3% | 47.1% |
Non-Melanoma Skin Cancer | 6.5% | 8.5% | 6.8% | 0.0% | 13.6% | 20.0% | 2.0% |